Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
Overview
Authors
Affiliations
In addition to physical barriers, neutrophils are considered a part of the first line of immune defense. They can be found in the bloodstream, with a lifespan of 6-8 h, and in tissue, where they can last up to 7 days. The mechanisms that neutrophils utilize for host defense are phagocytosis, degranulation, cytokine production, and, the most recently described, neutrophil extracellular trap (NET) production. NETs are DNA structures released due to chromatin decondensation and spreading, and they thus occupy three to five times the volume of condensed chromatin. Several proteins adhere to NETs, including histones and over 30 components of primary and secondary granules, among them components with bactericidal activity such as elastase, myeloperoxidase, cathepsin G, lactoferrin, pentraxin 3, gelatinase, proteinase 3, LL37, peptidoglycan-binding proteins, and others with bactericidal activity able to destroy virulence factors. Three models for NETosis are known to date. (a) , with a duration of 2-4 h, is the best described model. (b) In vital NETosis with nuclear DNA release, neutrophils release NETs without exhibiting loss of nuclear or plasma membrane within 5-60 min, and it is independent of reactive oxygen species (ROS) and the Raf/MERK/ERK pathway. (c) The final type is vital NETosis with release of mitochondrial DNA that is dependent on ROS and produced after stimuli with GM-CSF and lipopolysaccharide. Recent research has revealed neutrophils as more sophisticated immune cells that are able to precisely regulate their granular enzymes release by ion fluxes and can release immunomodulatory cytokines and chemokines that interact with various components of the immune system. Therefore, they can play a key role in autoimmunity and in autoinflammatory and metabolic diseases. In this review, we intend to show the two roles played by neutrophils: as a first line of defense against microorganisms and as a contributor to the pathogenesis of various illnesses, such as autoimmune, autoinflammatory, and metabolic diseases.
Zhang H, Guo R, Han Y, Yao Z, Quan M, Li B Front Neurol. 2025; 16:1548196.
PMID: 40035034 PMC: 11873095. DOI: 10.3389/fneur.2025.1548196.
Kim J, Han H Front Vet Sci. 2025; 12:1470605.
PMID: 40012748 PMC: 11862914. DOI: 10.3389/fvets.2025.1470605.
Retter A, Singer M, Annane D Crit Care. 2025; 29(1):59.
PMID: 39905519 PMC: 11796136. DOI: 10.1186/s13054-025-05283-0.
Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation.
Ci Z, Wang H, Luo J, Wei C, Chen J, Wang D Int J Nanomedicine. 2024; 19:13925-13946.
PMID: 39735324 PMC: 11682674. DOI: 10.2147/IJN.S497590.
Immunologic cell deaths: involvement in the pathogenesis and intervention therapy of periodontitis.
Tang C Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39718617 DOI: 10.1007/s00210-024-03732-1.